E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 8/12/2014 in the Prospect News Structured Products Daily.

New Issue: HSBC prices $6.43 million contingent income autocallables on Biogen Idec

By Jennifer Chiou

New York, Aug. 12 – HSBC USA Inc. priced $6,429,440 of contingent income autocallable securities due Aug. 13, 2015 linked to the common stock of Biogen Idec Inc., according to a 424B2 filing with the Securities and Exchange Commission.

If Biogen Idec shares close at or above the downside threshold level, 75% of the initial share price, on a quarterly determination date, the notes will pay a contingent payment that quarter at an annualized rate of 9.4%.

The notes will be called at par of $10 plus the contingent coupon if Biogen Idec shares close at or above the initial share price on any of the first three quarterly determination dates.

If the final share price is greater than or equal to the downside threshold level, the payout at maturity will be par plus the final contingent coupon. Otherwise, investors will receive a number of Biogen Idec shares equal to $10 divided by the initial share price or, at the issuer’s option, an amount in cash equal to the value of those shares.

HSBC Securities (USA) Inc. is the agent. Morgan Stanley Wealth Management is the distributor.

Issuer:HSBC USA Inc.
Issue:Contingent income autocallable securities
Underlying stock:Biogen Idec Inc. (Symbol: BIIB)
Amount:$6,429,440
Maturity:Aug. 13, 2015
Coupon:9.4% per year, payable quarterly if Biogen Idec shares close at or above downside threshold level on determination date for that quarter
Price:Par of $10
Payout at maturity:If final share price is greater than or equal to downside threshold level, par plus final contingent coupon; otherwise, a number of Biogen Idec shares equal to $10 divided by initial share price or, at issuer’s option, value of those shares in cash
Call:Automatically at par plus contingent coupon if Biogen Idec shares close at or above initial share price on any quarterly determination date other than final determination date
Initial share price:$324.05
Downside threshold:$243.04, 75% of initial share price
Pricing date:Aug. 8
Settlement date:Aug. 13
Agent:HSBC Securities (USA) Inc.
Distributor:Morgan Stanley Wealth Management
Fees:1.5%
Cusip:40434D707

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.